id	sid	eid	entity	type
cusj-5580	1	1	microsoft	ORG
cusj-5580	1	2	cusj 21.docx	PERSON
cusj-5580	170	1	21	CARDINAL
cusj-5580	170	2	tasigna	PERSON
cusj-5580	170	3	over 100,000	CARDINAL
cusj-5580	170	4	u.s.	GPE
cusj-5580	170	5	novartis	ORG
cusj-5580	170	6	well over $2 billion usd	MONEY
cusj-5580	170	7	2016	DATE
cusj-5580	171	1	novartis	ORG
cusj-5580	171	2	tasigna	PERSON
cusj-5580	171	3	2023	CARDINAL
cusj-5580	172	1	novartis	ORG
cusj-5580	172	2	tasigna	PERSON
cusj-5580	173	1	multiple days	DATE
cusj-5580	173	2	nearly a dozen	CARDINAL
cusj-5580	174	1	fewer than four	CARDINAL
cusj-5580	174	2	less than 24 hours	TIME
cusj-5580	174	3	85%	PERCENT
cusj-5580	177	1	15%	PERCENT
cusj-5580	177	2	u.s.	GPE
cusj-5580	177	3	1150 kg	QUANTITY
cusj-5580	177	4	/year	DATE
cusj-5580	178	1	1150 kg	QUANTITY
cusj-5580	179	1	$250 million usd/year	MONEY
cusj-5580	179	2	60%	PERCENT
cusj-5580	181	1	i.	PERSON
cusj-5580	182	1	8year	CARDINAL
cusj-5580	182	2	15%	PERCENT
cusj-5580	182	3	the 1980s	DATE
cusj-5580	182	4	nearly 90%	PERCENT
cusj-5580	182	5	2012	DATE
cusj-5580	182	6	kantarjian	NORP
cusj-5580	182	7	2012	DATE
cusj-5580	183	1	today	DATE
cusj-5580	183	2	over 10,000	CARDINAL
cusj-5580	183	3	each year	DATE
cusj-5580	183	4	2014	DATE
cusj-5580	184	1	novartis	ORG
cusj-5580	184	2	first	ORDINAL
cusj-5580	184	3	2016	DATE
cusj-5580	185	1	novartis	ORG
cusj-5580	185	2	second	ORDINAL
cusj-5580	185	3	tasigna	PERSON
cusj-5580	186	1	1	CARDINAL
cusj-5580	186	2	tasigna	PERSON
cusj-5580	186	3	first	ORDINAL
cusj-5580	186	4	huang et al.	PERSON
cusj-5580	186	5	2007	DATE
cusj-5580	187	1	tasigna	PERSON
cusj-5580	187	2	fda	ORG
cusj-5580	187	3	2010	DATE
cusj-5580	188	1	novartis	ORG
cusj-5580	188	2	tasigna	PERSON
cusj-5580	188	3	2023	CARDINAL
cusj-5580	189	1	tasigna	PERSON
cusj-5580	189	2	novartis	ORG
cusj-5580	189	3	tasigna	PERSON
cusj-5580	190	1	2015	CARDINAL
cusj-5580	190	2	tasigna	PERSON
cusj-5580	190	3	12.8%	PERCENT
cusj-5580	190	4	2015	DATE
cusj-5580	191	1	112,000	CARDINAL
cusj-5580	191	2	2020	DATE
cusj-5580	191	3	2012	DATE
cusj-5580	192	1	the year	DATE
cusj-5580	192	2	novartis	ORG
cusj-5580	192	3	tasigna	PERSON
cusj-5580	192	4	at least 140,000	CARDINAL
cusj-5580	192	5	us	GPE
cusj-5580	193	1	tasigna	PERSON
cusj-5580	193	2	one year	DATE
cusj-5580	193	3	approximately $100,000	MONEY
cusj-5580	193	4	novartis	ORG
cusj-5580	194	1	tasigna	PERSON
cusj-5580	194	2	tasigna	PERSON
cusj-5580	195	1	1	CARDINAL
cusj-5580	197	1	generic tasigna	PERSON
cusj-5580	199	1	novartis	ORG
cusj-5580	199	2	tasigna	PERSON
cusj-5580	200	1	tens of thousands	CARDINAL
cusj-5580	201	1	generic tasigna	PERSON
cusj-5580	202	1	four	CARDINAL
cusj-5580	202	2	justin m. cheung*	PERSON
cusj-5580	202	3	jessica hofflich	PERSON
cusj-5580	202	4	jian huang	PERSON
cusj-5580	202	5	nafiul jami department of materials science & chemical	ORG
cusj-5580	202	6	stony brook university	ORG
cusj-5580	202	7	2019	DATE
cusj-5580	372	1	22	CARDINAL
cusj-5580	372	2	1	CARDINAL
cusj-5580	372	3	novartis	ORG
cusj-5580	372	4	2	CARDINAL
cusj-5580	372	5	3	CARDINAL
cusj-5580	372	6	4	CARDINAL
cusj-5580	373	1	novartis	ORG
cusj-5580	373	2	tasigna	PERSON
cusj-5580	373	3	three	CARDINAL
cusj-5580	373	4	firstly	ORDINAL
cusj-5580	375	1	nci	ORG
cusj-5580	376	1	secondly	ORDINAL
cusj-5580	376	2	novartis	LOC
cusj-5580	376	3	u.s.	GPE
cusj-5580	376	4	tasigna	PERSON
cusj-5580	376	5	novartis	ORG
cusj-5580	377	1	thirdly	ORDINAL
cusj-5580	377	2	seven	CARDINAL
cusj-5580	377	3	1	CARDINAL
cusj-5580	377	4	2	CARDINAL
cusj-5580	377	5	3	CARDINAL
cusj-5580	377	6	4	CARDINAL
cusj-5580	377	7	5	CARDINAL
cusj-5580	377	8	6	CARDINAL
cusj-5580	377	9	7	CARDINAL
cusj-5580	378	1	7	CARDINAL
cusj-5580	385	1	two	CARDINAL
cusj-5580	385	2	american	NORP
cusj-5580	385	3	dominion tank & vessel co.	ORG
cusj-5580	385	4	inc.	ORG
cusj-5580	385	5	richmond	GPE
cusj-5580	385	6	virginia	GPE
cusj-5580	385	7	procedyne inc.	ORG
cusj-5580	385	8	new brunswick	GPE
cusj-5580	385	9	nj	ORG
cusj-5580	385	10	a. chemical	PERSON
cusj-5580	385	11	approximately 20%	PERCENT
cusj-5580	385	12	tasigna	PERSON
cusj-5580	385	13	sanford et al.	PERSON
cusj-5580	385	14	2014	DATE
cusj-5580	386	1	the year	DATE
cusj-5580	386	2	2023	CARDINAL
cusj-5580	386	3	approximately 28,000	CARDINAL
cusj-5580	387	1	approximately 15%	PERCENT
cusj-5580	387	2	us	GPE
cusj-5580	387	3	about 4200	CARDINAL
cusj-5580	388	1	the food and drug administration	ORG
cusj-5580	388	2	fda	ORG
cusj-5580	388	3	0.3 mg	QUANTITY
cusj-5580	388	4	daily	DATE
cusj-5580	388	5	approximately 230	CARDINAL
cusj-5580	388	6	2013	DATE
cusj-5580	389	1	15%	PERCENT
cusj-5580	389	2	at least 1150	CARDINAL
cusj-5580	389	3	/year	DATE
cusj-5580	390	1	tasigna	PERSON
cusj-5580	390	2	600,000	MONEY
cusj-5580	391	1	1150 kg	QUANTITY
cusj-5580	391	2	$690 million	MONEY
cusj-5580	393	1	1st	ORDINAL
cusj-5580	393	2	tasigna	PERSON
cusj-5580	394	1	2016	DATE
cusj-5580	394	2	~$146,000	ORG
cusj-5580	395	1	kantarjian	NORP
cusj-5580	395	2	2016	DATE
cusj-5580	396	1	60%	PERCENT
cusj-5580	396	2	first	ORDINAL
cusj-5580	397	1	60%	PERCENT
cusj-5580	397	2	tasigna	PERSON
cusj-5580	397	3	tasigna	PERSON
cusj-5580	397	4	240	MONEY
cusj-5580	397	5	1150 kg	QUANTITY
cusj-5580	397	6	$276 million	MONEY
cusj-5580	398	1	15%	PERCENT
cusj-5580	398	2	2023	CARDINAL
cusj-5580	398	3	about 4200	CARDINAL
cusj-5580	399	1	1150 kg	QUANTITY
cusj-5580	400	1	60%	PERCENT
cusj-5580	400	2	yearly	DATE
cusj-5580	400	3	$276 million	MONEY
cusj-5580	570	1	23	CARDINAL
cusj-5580	571	1	novartis	LOC
cusj-5580	572	1	2	CARDINAL
cusj-5580	572	2	al.	GPE
cusj-5580	572	3	2004	DATE
cusj-5580	573	1	fig	ORG
cusj-5580	574	1	2	CARDINAL
cusj-5580	574	2	novartis	ORG
cusj-5580	574	3	tasigna	PERSON
cusj-5580	574	4	2013	DATE
cusj-5580	575	1	three	CARDINAL
cusj-5580	576	1	first	ORDINAL
cusj-5580	577	1	2	CARDINAL
cusj-5580	578	1	second	ORDINAL
cusj-5580	579	1	2	CARDINAL
cusj-5580	580	1	third	ORDINAL
cusj-5580	581	1	2	CARDINAL
cusj-5580	582	1	four	CARDINAL
cusj-5580	582	2	novartis	ORG
cusj-5580	583	1	1	CARDINAL
cusj-5580	584	1	2	CARDINAL
cusj-5580	584	2	two	CARDINAL
cusj-5580	585	1	two	CARDINAL
cusj-5580	585	2	only one	CARDINAL
cusj-5580	585	3	2013	DATE
cusj-5580	586	1	novartis	ORG
cusj-5580	587	1	2	CARDINAL
cusj-5580	588	1	2	CARDINAL
cusj-5580	590	1	68 hours	TIME
cusj-5580	591	1	3	CARDINAL
cusj-5580	594	1	4	CARDINAL
cusj-5580	596	1	novartis	ORG
cusj-5580	596	2	over 100 hours	TIME
cusj-5580	596	3	an estimated 50 hours	TIME
cusj-5580	597	1	novartis	ORG
cusj-5580	599	1	five	CARDINAL
cusj-5580	599	2	1	CARDINAL
cusj-5580	600	1	1	CARDINAL
cusj-5580	602	1	2	CARDINAL
cusj-5580	602	2	novartis	ORG
cusj-5580	603	1	cusj 2019	PERSON
cusj-5580	773	1	24	CARDINAL
cusj-5580	773	2	100h	ORG
cusj-5580	773	3	ueda et al.	PERSON
cusj-5580	773	4	2012	DATE
cusj-5580	774	1	chen	PERSON
cusj-5580	774	2	68 hours	TIME
cusj-5580	774	3	three days	DATE
cusj-5580	775	1	chen	PERSON
cusj-5580	775	2	around 40%	PERCENT
cusj-5580	776	1	1a	CARDINAL
cusj-5580	776	2	chen	PERSON
cusj-5580	776	3	chen et al.	PERSON
cusj-5580	776	4	2009	DATE
cusj-5580	777	1	five days	DATE
cusj-5580	778	1	2010	DATE
cusj-5580	779	1	only four	CARDINAL
cusj-5580	779	2	250	CARDINAL
cusj-5580	779	3	2013	DATE
cusj-5580	780	1	1	CARDINAL
cusj-5580	781	1	five	CARDINAL
cusj-5580	783	1	1	CARDINAL
cusj-5580	784	1	3	CARDINAL
cusj-5580	785	1	al.	PERSON
cusj-5580	785	2	2012	DATE
cusj-5580	786	1	three	CARDINAL
cusj-5580	786	2	approximately 24 hours	TIME
cusj-5580	788	1	3	CARDINAL
cusj-5580	790	1	only four	CARDINAL
cusj-5580	790	2	1	CARDINAL
cusj-5580	790	3	3-amino-5	QUANTITY
cusj-5580	790	4	2	CARDINAL
cusj-5580	790	5	4-methylimidazole	QUANTITY
cusj-5580	790	6	3	CARDINAL
cusj-5580	790	7	4	CARDINAL
cusj-5580	790	8	4	CARDINAL
cusj-5580	794	1	2010	DATE
cusj-5580	796	1	4.	CARDINAL
cusj-5580	966	1	25	CARDINAL
cusj-5580	966	2	4	CARDINAL
cusj-5580	967	1	firstly	ORDINAL
cusj-5580	968	1	1	CARDINAL
cusj-5580	968	2	2	CARDINAL
cusj-5580	968	3	3	CARDINAL
cusj-5580	968	4	4	CARDINAL
cusj-5580	973	1	5	CARDINAL
cusj-5580	975	1	1150 kg	QUANTITY
cusj-5580	977	1	98%	PERCENT
cusj-5580	978	1	1150 kg	QUANTITY
cusj-5580	978	2	at least 350 days of the year	DATE
cusj-5580	979	1	137	CARDINAL
cusj-5580	979	2	0.263	CARDINAL
cusj-5580	980	1	90%	PERCENT
cusj-5580	980	2	95%	PERCENT
cusj-5580	980	3	90%	PERCENT
cusj-5580	980	4	three	CARDINAL
cusj-5580	980	5	approximately 0.325	CARDINAL
cusj-5580	981	1	2	CARDINAL
cusj-5580	982	1	138	CARDINAL
cusj-5580	982	2	1150 kg	QUANTITY
cusj-5580	984	1	3	CARDINAL
cusj-5580	984	2	5	CARDINAL
cusj-5580	985	1	cusj 2019	PERSON
cusj-5580	1155	1	26	CARDINAL
cusj-5580	1155	2	2	CARDINAL
cusj-5580	1155	3	chemcad	ORG
cusj-5580	1155	4	3	CARDINAL
cusj-5580	1156	1	chemcad	ORG
cusj-5580	1158	1	at least 1150 kg	QUANTITY
cusj-5580	1160	1	1150 kg	QUANTITY
cusj-5580	1161	1	$2 million	MONEY
cusj-5580	1164	1	$1,100,000$1,400,000 usd	MONEY
cusj-5580	1165	1	50,000	MONEY
cusj-5580	1165	2	annual	DATE
cusj-5580	1166	1	epa	ORG
cusj-5580	1166	2	200,000	MONEY
cusj-5580	1166	3	annual	DATE
cusj-5580	1167	1	500,000	MONEY
cusj-5580	1167	2	yearly	DATE
cusj-5580	1171	1	316l	CARDINAL
cusj-5580	1172	1	three 0.15 m3	QUANTITY
cusj-5580	1172	2	75,600	MONEY
cusj-5580	1173	1	at least 300 feet	QUANTITY
cusj-5580	1173	2	316l	CARDINAL
cusj-5580	1173	3	1	CARDINAL
cusj-5580	1173	4	8,850	MONEY
cusj-5580	1175	1	55,100	MONEY
cusj-5580	1176	1	140,000	MONEY
cusj-5580	1177	1	the year	DATE
cusj-5580	1179	1	four	CARDINAL
cusj-5580	1179	2	4	CARDINAL
cusj-5580	1181	1	around $5,500,000	MONEY
cusj-5580	1181	2	4	CARDINAL
cusj-5580	1182	1	the first year	DATE
cusj-5580	1182	2	$12 million	MONEY
cusj-5580	1182	3	around $8 million	MONEY
cusj-5580	1182	4	5	CARDINAL
cusj-5580	1182	5	$276 million dollars	MONEY
cusj-5580	1182	6	4.2%	PERCENT
cusj-5580	1182	7	2.8%	PERCENT
cusj-5580	1182	8	first	ORDINAL
cusj-5580	1351	1	27 second year	DATE
cusj-5580	1352	1	yearly	DATE
cusj-5580	1352	2	greater than $250 million	MONEY
cusj-5580	1352	3	15%	PERCENT
cusj-5580	1353	1	5	CARDINAL
cusj-5580	1355	1	8	CARDINAL
cusj-5580	1355	2	97 hours	TIME
cusj-5580	1356	1	3	CARDINAL
cusj-5580	1356	2	24 hours	TIME
cusj-5580	1358	1	1150 kg	QUANTITY
cusj-5580	1358	2	novartis	ORG
cusj-5580	1359	1	novartis	ORG
cusj-5580	1359	2	2023	CARDINAL
cusj-5580	1360	1	15%	PERCENT
cusj-5580	1360	2	1150 kg	QUANTITY
cusj-5580	1360	3	$276 million	MONEY
cusj-5580	1360	4	60%	PERCENT
cusj-5580	1366	1	asme	PERSON
cusj-5580	1366	2	american	NORP
cusj-5580	1366	3	epa	ORG
cusj-5580	1366	4	fda	ORG
cusj-5580	1366	5	food and drug	ORG
cusj-5580	1366	6	hazop	PERSON
cusj-5580	1366	7	nci	ORG
cusj-5580	1366	8	osha	DATE
cusj-5580	1368	1	devinder mahajan	PERSON
cusj-5580	1369	1	1	CARDINAL
cusj-5580	1369	2	h. kantarjian	PERSON
cusj-5580	1369	3	s. o’brien	PERSON
cusj-5580	1369	4	e. jabbour	PERSON
cusj-5580	1369	5	j. cortes	PERSON
cusj-5580	1369	6	2012	DATE
cusj-5580	1369	7	119(9	CARDINAL
cusj-5580	1369	8	1981–1987	CARDINAL
cusj-5580	1370	1	2	CARDINAL
cusj-5580	1370	2	2014	DATE
cusj-5580	1372	1	3	CARDINAL
cusj-5580	1372	2	w. huang	PERSON
cusj-5580	1372	3	w. c. shakespeare	PERSON
cusj-5580	1372	4	2007	DATE
cusj-5580	1372	5	14	DATE
cusj-5580	1372	6	2121-2124	DATE
cusj-5580	1373	1	https://www.thiemeconnect.com/products/ejournals/html/10.1055/s2007-983754	PERSON
cusj-5580	1374	1	4	CARDINAL
cusj-5580	1374	2	l. m.	PERSON
cusj-5580	1374	3	d., & eaddy	ORG
cusj-5580	1374	4	m. am	PERSON
cusj-5580	1375	1	2015	DATE
cusj-5580	1375	2	8(9	CARDINAL
cusj-5580	1375	3	472–480	CARDINAL
cusj-5580	1377	1	5	CARDINAL
cusj-5580	1377	2	j. cortes	PERSON
cusj-5580	1377	3	x. huang	PERSON
cusj-5580	1377	4	h. kantarjian	PERSON
cusj-5580	1377	5	2012	DATE
cusj-5580	1377	6	118(12	CARDINAL
cusj-5580	1377	7	3123-3127	CARDINAL
cusj-5580	1378	1	6	CARDINAL
cusj-5580	1378	2	d. sanford	PERSON
cusj-5580	1378	3	r. kyle	PERSON
cusj-5580	1378	4	a. lazo-langer	PERSON
cusj-5580	1378	5	a. xenocostas	PERSON
cusj-5580	1378	6	i. chin-yee	PERSON
cusj-5580	1378	7	k. howson-jan	PERSON
cusj-5580	1378	8	c. hsia	PERSON
cusj-5580	1378	9	2014	DATE
cusj-5580	1378	10	21(2	CARDINAL
cusj-5580	1378	11	241	CARDINAL
cusj-5580	1380	1	7	CARDINAL
cusj-5580	1380	2	fda	ORG
cusj-5580	1380	3	2013	DATE
cusj-5580	1381	1	8	CARDINAL
cusj-5580	1381	2	h. kantarjian	PERSON
cusj-5580	1382	1	u.s.	GPE
cusj-5580	1383	1	2016	DATE
cusj-5580	1554	1	28	CARDINAL
cusj-5580	1555	1	9	CARDINAL
cusj-5580	1555	2	w. breitenstein	PERSON
cusj-5580	1555	3	furet	CARDINAL
cusj-5580	1555	4	s. jacob	PERSON
cusj-5580	1555	5	w. manley	PERSON
cusj-5580	1555	6	united states	GPE
cusj-5580	1555	7	2004	DATE
cusj-5580	1558	1	10	CARDINAL
cusj-5580	1558	2	b. j. deadman	PERSON
cusj-5580	1558	3	m. d. hopkin	PERSON
cusj-5580	1558	4	i. r. baxendale	PERSON
cusj-5580	1558	5	s. v. ley	PERSON
cusj-5580	1558	6	biomol	PERSON
cusj-5580	1558	7	chem.	ORG
cusj-5580	1558	8	2013	DATE
cusj-5580	1558	9	11(11	CARDINAL
cusj-5580	1558	10	1766-1800	DATE
cusj-5580	1560	1	11	CARDINAL
cusj-5580	1560	2	y. chen	PERSON
cusj-5580	1560	3	l. wang	PERSON
cusj-5580	1560	4	h. zhou	PERSON
cusj-5580	1560	5	c. wang	PERSON
cusj-5580	1560	6	zhongguo yiyao	PERSON
cusj-5580	1560	7	zazhi	GPE
cusj-5580	1560	8	2009	DATE
cusj-5580	1560	9	40	DATE
cusj-5580	1560	10	401–403	CARDINAL
cusj-5580	1561	1	12	CARDINAL
cusj-5580	1561	2	a. yeori	PERSON
cusj-5580	1561	3	y. wang	PERSON
cusj-5580	1561	4	j. li	PERSON
cusj-5580	1561	5	j. zhu	PERSON
cusj-5580	1561	6	r. lifshitz-liron	PERSON
cusj-5580	1561	7	united states	GPE
cusj-5580	1561	8	2010	DATE
cusj-5580	1563	1	13	CARDINAL
cusj-5580	1563	2	s. ueda	PERSON
cusj-5580	1563	3	m. su	PERSON
cusj-5580	1563	4	s. l. buchwald	PERSON
cusj-5580	1563	5	j. of	PERSON
cusj-5580	1563	6	american	NORP
cusj-5580	1563	7	2012	DATE
cusj-5580	1563	8	134(1	CARDINAL
cusj-5580	1563	9	700	CARDINAL
cusj-5580	1564	1	14	CARDINAL
cusj-5580	1564	2	m. d. hopkin	PERSON
cusj-5580	1564	3	i. r. baxendale	PERSON
cusj-5580	1564	4	s. v. ley	PERSON
cusj-5580	1564	5	rsc chemcomm	PERSON
cusj-5580	1564	6	2010	DATE
cusj-5580	1564	7	46	DATE
cusj-5580	1564	8	2450-2452	DATE